Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Genetivision Corporation in September, 2022 for $893,628.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44GM148146-01 | Phase II | 893,628 | September 1, 2022 | |||||||
A SBIR Phase II contract was awarded to Genetivision Corporation in August, 2017 for $1,547,706.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44GM112248-02 | Phase II | 1,547,706 | August 15, 2017 | |||||||
A SBIR Phase I contract was awarded to Genetivision Corporation for $197,666.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM099188-01A1 | Phase I | 197,666 | ||||||||
A SBIR Phase I contract was awarded to Genetivision Corporation for $219,679.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM112248-01 | Phase I | 219,679 | ||||||||
A SBIR Phase II contract was awarded to Genetivision Corporation for $2,293,693.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44GM099188-02 | Phase II | 2,293,693 |